Unique ID issued by UMIN | UMIN000026829 |
---|---|
Receipt number | R000030797 |
Scientific Title | Comparative study between effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation -Investigasion using flash glucose monitoring system- |
Date of disclosure of the study information | 2017/06/01 |
Last modified on | 2018/09/07 14:15:25 |
Comparative study between effects of insulin degludec and glargine U300 on nighttime
blood glucose fluctuation
-Investigasion using flash glucose monitoring system-
Effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation
Comparative study between effects of insulin degludec and glargine U300 on nighttime
blood glucose fluctuation
-Investigasion using flash glucose monitoring system-
Effects of insulin degludec and glargine U300 on nighttime blood glucose fluctuation
Japan |
diabetes mellitus
Endocrinology and Metabolism |
Others
NO
We will compare the effect of insulin degludec and insulin glargine U300 on nocturnal blood glucose fluctuation using FGM (Flash Glucose Monitoring; Freestyle Libre Pro).
Safety,Efficacy
Exploratory
Phase IV
For the first 5 days and last 5 days in the midnight to 6AM time zone
1 mean blood sugar level
2 Standard Deviation
3 Mean amplitude of glucose excursion
For the first 5 days and last 5 days in the midnight to 6 AM time zone
1 Percentage of time zone with blood glucose level less than 70 mg per dl and its AUC
2 Percentage of time zone with blood sugar level less than 50 mg per dl and its AUC
3 Percentage of time zone with blood glucose level 140 mg per dl and its AUC
Interventional
Cross-over
Randomized
Cluster
Open -no one is blinded
Active
2
Treatment
Medicine |
1 Install Freestyle Libre Pro (Abbott) for 2 weeks (one sensor).
2 From day 6, switch the basal insulin from insulin degludec to insulin glargine U300, while keeping the same number of units and injection time.
1 Install Freestyle Libre Pro (Abbott) for 2 weeks (one sensor).
2 From day 6, switch the basal insulin from insulin glargine U300 to insulin degludec, while keeping the same number of units and injection time.
20 | years-old | <= |
75 | years-old | > |
Male and Female
1 Outpatient visit or hospitalized patients
with diabetes
2 Continue to use insulin deglug or insulin glargine U 300 for three months or more, during which the contents of other diabetes remedies are unchanged
3 HbA1c (NGSP value) is 6% or more but less than 9%
1 Patients with a clear history of ischemic heart disease (angina, myocardial infarction), ischemic cerebrovascular disease
2 Patients with HbA1c fluctuating by 2% or more within 3 months
3 Severe ketosis, diabetic coma or prematurity
4 Patients with severe infection, preoperative, severe trauma
5 Cases judged by other physicians to be ineligible
50
1st name | |
Middle name | |
Last name | Yukihiro Bando |
Fukuiken Saiseikai Hospital
Internal medicine
Funabashi Wadanaka 7-1,Fukui,Fukui.Japan
0776231111
bando.yukihiro5002@fukui.saiseikai.or.jp
1st name | |
Middle name | |
Last name | Kazuo Notsumata |
Fukuiken Saisekai Hospital
Internal medicine
Funabashi Wadanaka 7-1,Fukui,Fukui.Japan
0776231111
bando.yukihiro5002@fukui.saiseikai.or.jp
Fukuiken Saisekai Hospital
no source of funding
Other
NO
2017 | Year | 06 | Month | 01 | Day |
Unpublished
Completed
2017 | Year | 04 | Month | 01 | Day |
2018 | Year | 03 | Month | 31 | Day |
2018 | Year | 04 | Month | 22 | Day |
2018 | Year | 05 | Month | 01 | Day |
2018 | Year | 05 | Month | 10 | Day |
2018 | Year | 05 | Month | 15 | Day |
2017 | Year | 04 | Month | 02 | Day |
2018 | Year | 09 | Month | 07 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030797